Loading…
Prescription Digital Therapeutics to Support Recovery Act
Legislative Progress
Introduced
March 18, 2020
Latest Action
March 18, 2020
Primary Sponsor
Shelley Moore CapitoRepublican(WV)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,086 other S bills in the 116th — cohort avg 30d
Prescription Digital Therapeutics to Support Recovery Act This bill provides for Medicare and Medicaid coverage of prescription digital therapeutics that use behavioral treatments to prevent, manage, or treat mental health or substance-use disorders.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2020 · fourth_quarter · Medicare/Medicaid
Drug shortage issues; issues related to medication assisted treatment S. 3532, the Prescription Digital Therapeutics to Support Recovery Act
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Drug shortage issues; issues related to medication assisted treatment S. 3532, the Prescription Digital Therapeutics to Support Recovery Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
H.R. 5333, Ensuring Patient Access to Critical Breakthrough Products Act of 2019, as it relates to Medicare coverage. S. 3532, Prescription Digital Therapeutics to Support Recovery Act, as it relates to Medicare coverage.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Pharmacy
Legislative and regulatory issues pertaining to Orexo. Implementation of the SUPPORT Act. Access to Digital Therapeutics (S. 3532) Digital Therapeutics Support Recovery Act.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Medicare/Medicaid
Drug shortage issues; issues related to medication assisted treatment S. 3532, the Prescription Digital Therapeutics to Support Recovery Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
Drug shortage issues; issues related to medication assisted treatment S. 3532, the Prescription Digital Therapeutics to Support Recovery Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Pharmacy
Legislative and regulatory issues pertaining to Orexo. Implementation of Comprehensive Addiction and Recovery Act 2016 (P.L. 114-255), 21st Century Cures Act. (P.L. 114-255)Support for Patients and Communities Act (P.L. 115-271) and CARES Act (P.L. 116-255) Access to Digital Therapeutics (S. 3532) Digital Therapeutics Support Recovery Act.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Medicare/Medicaid
H.R. 5333, Ensuring Patient Access to Critical Breakthrough Products Act of 2019, as it relates to Medicare coverage. S. 3532, Prescription Digital Therapeutics to Support Recovery Act, as it relates to Medicare coverage.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Medicare/Medicaid
H.R. 5333, Ensuring Patient Access to Critical Breakthrough Products Act of 2019, as it relates to Medicare coverage. S. 3532, Prescription Digital Therapeutics to Support Recovery Act, as it relates to Medicare coverage.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
Issues related to prescription digital therapeutics including S. 3532 - Prescription Digital Therapeutics to Support Recovery Act.
Client expense: Not reported · Firm income: Not reported
2020 · first_quarter · Medicare/Medicaid
H.R. 5333, Ensuring Patient Access to Critical Breakthrough Products Act of 2019, as it relates to Medicare coverage. S. 3532, Prescription Digital Therapeutics to Support Recovery Act, as it relates to Medicare coverage.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE